Do analysts rate IRIX or SKYA?

IRIDEX currently has a consensus target price of $3.00, indicating a potential upside of 237.15%. Given IRIDEX's stronger consensus rating and higher probable upside, research analysts clearly believe IRIDEX is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SNWV or IRIX more profitable?

Sanuwave Health has a net margin of 32.38% compared to IRIDEX's net margin of -6.23%. Sanuwave Health's return on equity of 8,163.31% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets Sanuwave Health 32.38% 8,163.31% 39.02% IRIDEX -6.23% N/A -11.16%

Which has higher earnings and valuation, NYXH or IRIX?

IRIDEX has higher revenue and earnings than Nyxoah. IRIDEX is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nyxoah $11.33M 5.44 -$101.92M -$2.52 N/A IRIDEX $52.67M 0.29 -$4.44M -$0.19 N/A

Is NYXH or IRIX more profitable?

IRIDEX has a net margin of -6.23% compared to Nyxoah's net margin of -443.16%. IRIDEX's return on equity of 0.00% beat Nyxoah's return on equity. Company Net Margins Return on Equity Return on Assets Nyxoah -443.16% -178.90% -81.83% IRIDEX -6.23% N/A -11.16%

Which has preferable valuation and earnings, ECOR or IRIX?

IRIDEX has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio electroCore $36.97M 2.22 -$13.97M -$1.66 N/A IRIDEX $52.67M 0.29 -$4.44M -$0.19 N/A

Is ECOR or IRIX more profitable?

IRIDEX has a net margin of -6.23% compared to electroCore's net margin of -39.96%. IRIDEX's return on equity of 0.00% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -39.96% -1,956.38% -81.35% IRIDEX -6.23% N/A -11.16%

Which has better valuation and earnings, IRIX or DRIO?

IRIDEX has higher revenue and earnings than DarioHealth. IRIDEX is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.29 -$4.44M -$0.19 N/A DarioHealth $22.36M 2.52 -$41.71M -$8.88 N/A

Is IRIX or DRIO more profitable?

IRIDEX has a net margin of -6.23% compared to DarioHealth's net margin of -192.23%. IRIDEX's return on equity of 0.00% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% N/A -11.16% DarioHealth -192.23% -60.52% -37.08%

IRIDEX (IRIX) Competitors

$0.89 +0.05 (+5.69%)

Closing price 08/11/2026 04:00 PM Eastern

Extended Trading

$0.90 +0.01 (+0.58%)

As of 08/11/2026 05:27 PM Eastern

Compare

IRIX vs. SKYA, SNWV, NYXH, ECOR, and DRIO

Should you buy IRIDEX stock or one of its competitors? IRIDEX's main competitors and comparable companies include SkyAI, Inc. Common Stock (SKYA), Sanuwave Health (SNWV), Nyxoah (NYXH), electroCore (ECOR), and DarioHealth (DRIO). Companies are selected based on similarities in market, industry, and size.

How does IRIDEX compare to SkyAI, Inc. Common Stock?

IRIDEX (NASDAQ:IRIX) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are related small-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

IRIDEX has higher revenue and earnings than SkyAI, Inc. Common Stock. IRIDEX is trading at a lower price-to-earnings ratio than SkyAI, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.29	-$4.44M	-$0.19	N/A
SkyAI, Inc. Common Stock	$200K	249.28	-$282.50M	-$1.63	N/A

In the previous week, SkyAI, Inc. Common Stock had 1 more articles in the media than IRIDEX. MarketBeat recorded 2 mentions for SkyAI, Inc. Common Stock and 1 mentions for IRIDEX. SkyAI, Inc. Common Stock's average media sentiment score of 1.38 beat IRIDEX's score of 0.00 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
IRIDEX	Neutral
SkyAI, Inc. Common Stock	Positive

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%. IRIDEX's return on equity of 0.00% beat SkyAI, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	N/A	-11.16%
SkyAI, Inc. Common Stock	N/A	-129.58%	-127.02%

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Comparatively, 1.2% of SkyAI, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

IRIDEX has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.06, indicating that its share price is 106% more volatile than the broader market.

IRIDEX currently has a consensus target price of $3.00, indicating a potential upside of 237.15%. Given IRIDEX's stronger consensus rating and higher probable upside, research analysts clearly believe IRIDEX is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

IRIDEX beats SkyAI, Inc. Common Stock on 10 of the 16 factors compared between the two stocks.

How does IRIDEX compare to Sanuwave Health?

Sanuwave Health (NASDAQ:SNWV) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

In the previous week, Sanuwave Health had 6 more articles in the media than IRIDEX. MarketBeat recorded 7 mentions for Sanuwave Health and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.00 beat Sanuwave Health's score of -0.47 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Sanuwave Health	Neutral
IRIDEX	Neutral

42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by insiders. Comparatively, 8.6% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Sanuwave Health has higher earnings, but lower revenue than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	1.07	$11.81M	$0.24	22.92
IRIDEX	$52.67M	0.29	-$4.44M	-$0.19	N/A

Sanuwave Health has a net margin of 32.38% compared to IRIDEX's net margin of -6.23%. Sanuwave Health's return on equity of 8,163.31% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	8,163.31%	39.02%
IRIDEX	-6.23%	N/A	-11.16%

Sanuwave Health has a beta of 1.48, meaning that its share price is 48% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market.

Sanuwave Health presently has a consensus target price of $51.00, indicating a potential upside of 827.27%. IRIDEX has a consensus target price of $3.00, indicating a potential upside of 237.15%. Given Sanuwave Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Sanuwave Health is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Sanuwave Health beats IRIDEX on 14 of the 16 factors compared between the two stocks.

How does IRIDEX compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

IRIDEX has higher revenue and earnings than Nyxoah. IRIDEX is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	5.44	-$101.92M	-$2.52	N/A
IRIDEX	$52.67M	0.29	-$4.44M	-$0.19	N/A

Nyxoah currently has a consensus price target of $5.26, indicating a potential upside of 230.94%. IRIDEX has a consensus price target of $3.00, indicating a potential upside of 237.15%. Given IRIDEX's higher possible upside, analysts plainly believe IRIDEX is more favorable than Nyxoah.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Nyxoah had 7 more articles in the media than IRIDEX. MarketBeat recorded 8 mentions for Nyxoah and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.00 beat Nyxoah's score of -0.48 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Nyxoah	Neutral
IRIDEX	Neutral

Nyxoah has a beta of 1.62, meaning that its stock price is 62% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

IRIDEX has a net margin of -6.23% compared to Nyxoah's net margin of -443.16%. IRIDEX's return on equity of 0.00% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-443.16%	-178.90%	-81.83%
IRIDEX	-6.23%	N/A	-11.16%

20.1% of IRIDEX shares are held by institutional investors. 8.6% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

IRIDEX beats Nyxoah on 10 of the 16 factors compared between the two stocks.

How does IRIDEX compare to electroCore?

electroCore (NASDAQ:ECOR) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

In the previous week, electroCore had 22 more articles in the media than IRIDEX. MarketBeat recorded 23 mentions for electroCore and 1 mentions for IRIDEX. electroCore's average media sentiment score of 0.21 beat IRIDEX's score of 0.00 indicating that electroCore is being referred to more favorably in the media.

Company	Overall Sentiment
electroCore	Neutral
IRIDEX	Neutral

electroCore has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market.

IRIDEX has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$36.97M	2.22	-$13.97M	-$1.66	N/A
IRIDEX	$52.67M	0.29	-$4.44M	-$0.19	N/A

IRIDEX has a net margin of -6.23% compared to electroCore's net margin of -39.96%. IRIDEX's return on equity of 0.00% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
IRIDEX	-6.23%	N/A	-11.16%

26.7% of electroCore shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 7.8% of electroCore shares are held by company insiders. Comparatively, 8.6% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

electroCore presently has a consensus target price of $18.00, indicating a potential upside of 97.37%. IRIDEX has a consensus target price of $3.00, indicating a potential upside of 237.15%. Given IRIDEX's higher possible upside, analysts clearly believe IRIDEX is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

IRIDEX beats electroCore on 9 of the 14 factors compared between the two stocks.

How does IRIDEX compare to DarioHealth?

IRIDEX (NASDAQ:IRIX) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by insiders. Comparatively, 3.5% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

IRIDEX has higher revenue and earnings than DarioHealth. IRIDEX is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.29	-$4.44M	-$0.19	N/A
DarioHealth	$22.36M	2.52	-$41.71M	-$8.88	N/A

In the previous week, DarioHealth had 9 more articles in the media than IRIDEX. MarketBeat recorded 10 mentions for DarioHealth and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.00 equaled DarioHealth'saverage media sentiment score.

Company	Overall Sentiment
IRIDEX	Neutral
DarioHealth	Neutral

IRIDEX has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, DarioHealth has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

IRIDEX presently has a consensus price target of $3.00, indicating a potential upside of 237.15%. DarioHealth has a consensus price target of $10.50, indicating a potential upside of 36.90%. Given IRIDEX's higher probable upside, equities analysts plainly believe IRIDEX is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IRIDEX has a net margin of -6.23% compared to DarioHealth's net margin of -192.23%. IRIDEX's return on equity of 0.00% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	N/A	-11.16%
DarioHealth	-192.23%	-60.52%	-37.08%

Summary

IRIDEX beats DarioHealth on 8 of the 13 factors compared between the two stocks.

Get IRIDEX News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRIX vs. The Competition

Export

Metric	IRIDEX	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$14.65M	$5.86B	$7.09B	$12.96B
Dividend Yield	N/A	1.76%	2.57%	10.34%
P/E Ratio	-4.68	25.08	268.42	25.05
Price / Sales	0.29	62.95	593.28	87.62
Price / Cash	N/A	33.38	72.26	50.42
Price / Book	-14.83	5.89	13.21	6.18
Net Income	-$4.44M	$147.25M	$3.44B	$347.05M
7 Day Performance	5.41%	2.69%	2.09%	1.25%
1 Month Performance	-19.11%	2.44%	-0.23%	-0.64%
1 Year Performance	-31.55%	9.41%	70.31%	20.12%

IRIDEX Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRIX IRIDEX	1.8884 of 5 stars	$0.89 +5.7%	$3.00 +237.2%	-29.4%	$14.65M	$52.67M	N/A	120	Upcoming Earnings Gap Up
SKYA SkyAI, Inc. Common Stock	0.9828 of 5 stars	$1.39 -0.9%	N/A	-79.6%	$58.74M	$200K	N/A	55	Positive News Earnings Report
SNWV Sanuwave Health	2.9097 of 5 stars	$6.45 +1.3%	$51.00 +691.3%	-87.1%	$55.69M	$44.05M	19.62	40	Earnings Report Upcoming Earnings Gap Down
NYXH Nyxoah	3.3022 of 5 stars	$1.40 -2.1%	$5.96 +325.9%	-77.4%	$54.34M	$11.33M	N/A	110	Earnings Report Analyst Downgrade
ECOR electroCore	2.7906 of 5 stars	$6.00 -1.5%	$18.00 +200.0%	+111.6%	$54.12M	$32.03M	N/A	50	Trending News Earnings Report Analyst Revision Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRIX) was last updated on 8/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IRIDEX (IRIX) Competitors

IRIX vs. SKYA, SNWV, NYXH, ECOR, and DRIO

How does IRIDEX compare to SkyAI, Inc. Common Stock?

Summary

How does IRIDEX compare to Sanuwave Health?

Summary

How does IRIDEX compare to Nyxoah?

Summary

How does IRIDEX compare to electroCore?

Summary

How does IRIDEX compare to DarioHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IRIDEX (IRIX) Competitors

IRIX vs. SKYA, SNWV, NYXH, ECOR, and DRIO

How does IRIDEX compare to SkyAI, Inc. Common Stock?

Which has higher earnings & valuation, IRIX or SKYA?

Does the media refer more to IRIX or SKYA?

Is IRIX or SKYA more profitable?

Do insiders & institutionals hold more shares of IRIX or SKYA?

Which has more volatility & risk, IRIX or SKYA?

Do analysts rate IRIX or SKYA?

Summary

How does IRIDEX compare to Sanuwave Health?

Does the media prefer SNWV or IRIX?

Do institutionals & insiders believe in SNWV or IRIX?

Which has better valuation & earnings, SNWV or IRIX?

Is SNWV or IRIX more profitable?

Which has more volatility & risk, SNWV or IRIX?

Do analysts prefer SNWV or IRIX?

Summary

How does IRIDEX compare to Nyxoah?

Which has higher earnings and valuation, NYXH or IRIX?

Do analysts prefer NYXH or IRIX?

Does the media prefer NYXH or IRIX?

Which has more volatility and risk, NYXH or IRIX?

Is NYXH or IRIX more profitable?

Do insiders & institutionals believe in NYXH or IRIX?

Summary

How does IRIDEX compare to electroCore?

Does the media prefer ECOR or IRIX?

Which has more risk & volatility, ECOR or IRIX?

Which has preferable valuation and earnings, ECOR or IRIX?

Is ECOR or IRIX more profitable?

Do insiders and institutionals believe in ECOR or IRIX?

Do analysts prefer ECOR or IRIX?

Summary

How does IRIDEX compare to DarioHealth?

Do institutionals & insiders believe in IRIX or DRIO?

Which has better valuation and earnings, IRIX or DRIO?

Does the media favor IRIX or DRIO?

Which has more volatility and risk, IRIX or DRIO?

Do analysts recommend IRIX or DRIO?

Is IRIX or DRIO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools